Literature DB >> 3021869

Human rotavirus studies in volunteers: determination of infectious dose and serological response to infection.

R L Ward, D I Bernstein, E C Young, J R Sherwood, D R Knowlton, G M Schiff.   

Abstract

An unpassaged, safety-tested strain (CJN) of human rotavirus from a stool specimen of a hospitalized child was administered orally to 62 adult volunteers for determination of the dose required to produce infection with or without illness. Subjects ingested doses ranging from 9 X 10(-3) to 9 X 10(4) focus-forming units in buffered salt solution after consumption of 50 ml of 4% NaHCO3. The amount of virus in the inoculum required to cause infection (shedding of virus, seroconversion, or both) in study subjects was comparable to the minimum detectable in cultures of primary monkey kidney cells. Seventeen of 30 infected subjects became ill with doses equivalent to that required for infection. Although the preinoculation titers of serum neutralizing antibody to the challenge virus in study subjects ranged from less than 1:2 to 1:1,600, the concentration of serum antibody could not be correlated with protection from infection or illness in subjects given an infectious dose of virus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3021869     DOI: 10.1093/infdis/154.5.871

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  72 in total

1.  Attenuation of a human rotavirus vaccine candidate did not correlate with mutations in the NSP4 protein gene.

Authors:  R L Ward; B B Mason; D I Bernstein; D S Sander; V E Smith; G A Zandle; R S Rappaport
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Detection of human and animal rotavirus sequences in drinking water.

Authors:  B Gratacap-Cavallier; O Genoulaz; K Brengel-Pesce; H Soule; P Innocenti-Francillard; M Bost; L Gofti; D Zmirou; J M Seigneurin
Journal:  Appl Environ Microbiol       Date:  2000-06       Impact factor: 4.792

3.  Field study of the composition of greywater and comparison of microbiological indicators of water quality in on-site systems.

Authors:  Margaret Leonard; Brent Gilpin; Beth Robson; Katrina Wall
Journal:  Environ Monit Assess       Date:  2016-07-19       Impact factor: 2.513

4.  Application of cation-coated filter method to detection of noroviruses, enteroviruses, adenoviruses, and torque teno viruses in the Tamagawa River in Japan.

Authors:  Eiji Haramoto; Hiroyuki Katayama; Kumiko Oguma; Shinichiro Ohgaki
Journal:  Appl Environ Microbiol       Date:  2005-05       Impact factor: 4.792

5.  Quantitative microbial risk assessment models for consumption of raw vegetables irrigated with reclaimed water.

Authors:  Andrew J Hamilton; Frank Stagnitti; Robert Premier; Anne-Maree Boland; Glenn Hale
Journal:  Appl Environ Microbiol       Date:  2006-05       Impact factor: 4.792

6.  Development of a rotavirus-shedding model in rhesus macaques, using a homologous wild-type rotavirus of a new P genotype.

Authors:  Monica M McNeal; Karol Sestak; Anthony H-C Choi; Mitali Basu; Michael J Cole; Pyone P Aye; Rudolf P Bohm; Richard L Ward
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

7.  Characterization of VP6 genes from rotavirus strains collected in the United States from 1996-2002.

Authors:  Tara K Kerin; Erin M Kane; Roger I Glass; Jon R Gentsch
Journal:  Virus Genes       Date:  2007-06-13       Impact factor: 2.332

8.  Use of propidium monoazide in reverse transcriptase PCR to distinguish between infectious and noninfectious enteric viruses in water samples.

Authors:  Sandhya Parshionikar; Ian Laseke; G Shay Fout
Journal:  Appl Environ Microbiol       Date:  2010-05-14       Impact factor: 4.792

9.  In vivo protocol for testing efficacy of hand-washing agents against viruses and bacteria: experiments with rotavirus and Escherichia coli.

Authors:  S A Ansari; S A Sattar; V S Springthorpe; G A Wells; W Tostowaryk
Journal:  Appl Environ Microbiol       Date:  1989-12       Impact factor: 4.792

10.  Safety and immunogenicity of a live attenuated pentavalent rotavirus vaccine in HIV-exposed infants with or without HIV infection in Africa.

Authors:  Myron J Levin; Jane C Lindsey; Susan S Kaplan; Werner Schimana; Jody Lawrence; Monica M McNeal; Mutsa Bwakura-Dangarembizi; Anthony Ogwu; Evans M Mpabalwani; Paul Sato; George Siberry; Margaret Nelson; Darcy Hille; Geoffrey A Weinberg; Adriana Weinberg
Journal:  AIDS       Date:  2017-01-02       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.